NewLink Genetics Corporation
Pagina dedicata companiei NewLink Genetics Corporation listata cu simbolul US.NLNK
Descriere companie[edit | ]
Lumos Pharma Inc (www.newlinkgenetics.com) is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare and neglected diseases. The company's therapeutic candidate is LUM-201, an oral growth hormone stimulating small molecule, is in late-stage clinical development for the treatment of Pediatric Growth Hormone Deficiency (PGHD).
Grafic actiuni companie[edit | ]